About LevoSulbutamol Sulphate IP

Levosalbutamol Sulphate IP Pharmaceutical API | Orex Pharma Pvt Ltd

Product Overview

Orex Pharma Pvt Ltd offers Levosalbutamol Sulphate IP for pharmaceutical companies seeking quality-focused active pharmaceutical ingredients (APIs) for respiratory medicine formulations. Levosalbutamol Sulphate is a bronchodilator ingredient used in the development and manufacture of pharmaceutical products designed to help relieve bronchospasm and improve airflow in patients with respiratory conditions.

With a focus on quality, product consistency, and customer-oriented service, Orex Pharma Pvt Ltd serves the sourcing needs of pharmaceutical manufacturers, formulation companies, bulk drug buyers, pharmaceutical distributors, and international trading partners. We aim to support domestic and global procurement requirements through professional communication, product documentation, and dependable business relationships.

Product Specifications

• Product Name: Levosalbutamol Sulphate

• Pharmacopoeial Standard: IP, subject to the applicable product specification

• Product Category: Active Pharmaceutical Ingredient (API)

• Therapeutic Category: Respiratory Medicine / Bronchodilator

• Primary Application: Manufacturing of respiratory pharmaceutical formulations

• Industry: Pharmaceutical and Healthcare

• Supply Market: Domestic and international markets, subject to regulatory and commercial requirements

• Company: Orex Pharma Pvt Ltd

Pharmaceutical Applications

Levosalbutamol Sulphate is used as an active ingredient in the development and manufacture of suitable respiratory pharmaceutical formulations. Depending on the approved formulation, applicable specifications, and regulatory requirements, its applications may include:

• Inhalation and respiratory solutions

• Oral liquid formulations

• Other approved pharmaceutical dosage forms

• Respiratory medicine product development and manufacturing

Why Choose Orex Pharma Pvt Ltd?

Orex Pharma Pvt Ltd understands the importance of product quality, reliable sourcing, and consistent supply in the global pharmaceutical industry. We aim to build long-term business relationships with pharmaceutical companies and international buyers through a professional, customer-focused approach.

Our product offering is intended to support pharmaceutical procurement teams seeking:

• Quality-focused pharmaceutical API sourcing

• Product specifications and technical documentation

• Certificate of Analysis (COA), where available

• Bulk procurement enquiries

• International pharmaceutical sourcing partnerships

• Professional support for product and commercial enquiries

Global Supply and Business Enquiries

Orex Pharma Pvt Ltd welcomes enquiries from pharmaceutical manufacturers, API distributors, pharmaceutical importers, formulation developers, and bulk drug purchasers worldwide.

For information regarding Levosalbutamol Sulphate IP, including product specifications, quality documentation, packaging options, minimum order quantity, pricing, and export availability, contact Orex Pharma Pvt Ltd directly.

Orex Pharma Pvt Ltd Your Business Partner for Pharmaceutical API Sourcing and Global Pharmaceutical Supply.

Frequently Asked Questions

1. What is Levosalbutamol Sulphate?

Levosalbutamol Sulphate is a bronchodilator active ingredient used in suitable pharmaceutical formulations for respiratory conditions involving bronchospasm.

2. Who can enquire about Levosalbutamol Sulphate from Orex Pharma Pvt Ltd?

Pharmaceutical manufacturers, formulation companies, API distributors, importers, exporters, and authorised pharmaceutical procurement organisations can contact Orex Pharma Pvt Ltd for product and commercial information.

3. Is Levosalbutamol Sulphate available for bulk procurement?

Bulk procurement enquiries can be submitted to Orex Pharma Pvt Ltd. Availability, minimum order quantity, packaging, and supply terms are subject to confirmation.

4. What documentation can be requested?

Buyers may enquire about the Certificate of Analysis (COA), product specifications, Safety Data Sheet (SDS), and other applicable technical or regulatory documentation, subject to availability.

5. Does Orex Pharma Pvt Ltd support international enquiries?

Orex Pharma Pvt Ltd welcomes enquiries from international pharmaceutical buyers. Export availability, destination-country regulatory requirements, and commercial terms should be confirmed directly with the company.

High-Purity Bronchodilator API

Levosalbutamol Sulphate IP is synthesized for use in pharmaceutical formulations for asthma and COPD patients. It boasts a purity of over 99%, is odorless, white in appearance, and demonstrates precise control over physical characteristics such as particle size and bulk density. Its synthetic extraction method, low impurity profile, and stability make it a preferred choice for drug manufacturers seeking reliable efficacy and consistency in their final products.


Flexible Packaging and Superior Stability

The product is packed in double LDPE bags inside HDPE drums, ensuring superior protection against moisture and light. This packaging, combined with a storage recommendation of 15C to 30C and a shelf life of three years, maintains product stability and purity. Customizable particle sizing also ensures adaptability to varied formulation requirements for large-scale or specialized pharmaceutical applications.